Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 856 AL 870

The olfactory-glymphatic syndrome: linking smell dysfunction, cognitive impairment and sleep disturbances in neuropathological disorders

Phillips WT, Schwartz JG.

Front Neurosci. 2026 Aug 12;20:1897376. doi: 10.3389/fnins.2026.1897376. eCollection 2026.

Parietal Cortex Transcriptomics Refines Parkinson Disease GWAS Nomination and Highlights STAT3 as a Putative Upstream Glial Regulator

Alfradique-Dunham I, Sanford J, Liu M, Perrin RJ, Franklin EE, Norris S, Kotzbauer PT, Perlmutter JS, Budde JP, Cruchaga C, Ibanez L, Minaya M.

bioRxiv [Preprint]. 2026 Aug 18:2026.08.13.744719. doi: 10.64898/2026.08.13.744719.

Chronic Paraquat Neurotoxicity and Dopaminergic Degeneration: A Mechanistic Review

Riaz S, Ali S, Summer M, Iqbal A, Ashraf R, Bibi R.

Chem Biodivers. 2026 Sep;23(9):e71676. doi: 10.1002/cbdv.71676.

Rebalancing α-Synuclein Clearance: Novel Therapeutic Frontiers in Parkinson's Disease

Jabeen M, Hameed H, Ahmad SM, Mushtaq T, Khan MA, Hameed A.

Neuromolecular Med. 2026 Aug 31;28(1):51. doi: 10.1007/s12017-026-08948-3.

Nanotechnology-enabled delivery of bioactive compounds for neuroprotection in Parkinson's disease: mechanisms and future directions

Gaur P, Bisht PR, Lal Gupta S.

J Biomater Sci Polym Ed. 2026 Aug 29:1-31. doi: 10.1080/09205063.2026.2723464. Online ahead of print.

Psychosocial determinants of exercise behavior in Parkinson's disease: a mini-review

Zhang G.

Front Public Health. 2026 Sep 3;14:1942675. doi: 10.3389/fpubh.2026.1942675. eCollection 2026.

Efficacy and safety of extended-release carbidopa-levodopa (IPX203) versus immediate-release carbidopa-levodopa for Parkinson's disease: A systematic review

Attar A, Aljadani HH, Barwais KF, Alqsair AA, Alharbi FA, Alharith HM, Fallatah AA, Halabi MH, Hakami AY, Zagzoog N.

J Int Med Res. 2026 Sep;54(9):3000605261477638. doi: 10.1177/03000605261477638. Epub 2026 Sep 2.

The promise and challenges of focused ultrasound therapy in the management of Parkinson's disease

Paio F, Tinazzi M, Tamburin S.

Expert Rev Neurother. 2026 Sep 2:1-5. doi: 10.1080/14737175.2026.2725110. Online ahead of print.

Correction: Effects of Telehealth Interventions for People With Parkinson Disease: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Sun M, Tang F, Min L, Wen S, Wang S, Jiang H.

JMIR Mhealth Uhealth. 2026 Sep 1;14:e108495. doi: 10.2196/108495.

Clinical trials in late-stage Parkinson's disease

Fabbri M, Gallo S, Machado T, Pacilio P, Rascol O, Ferreira JJ.

J Parkinsons Dis. 2026 Sep 22:1877718X261491591. doi: 10.1177/1877718X261491591. Online ahead of print.

Biological heterogeneity in Parkinson's disease: implications for MRI-based patient stratification

Pokotylo MM, Brüggemann N, Prasuhn J.

NPJ Parkinsons Dis. 2026 Aug 27;12(1):207. doi: 10.1038/s41531-026-01544-z.

Reversible exacerbation of parkinsonism during epirubicin-cyclophosphamide chemotherapy in a patient with PTEN hamartoma tumor syndrome and young-onset Parkinson's disease

Wakamatsu N, Norimura S, Nakagawa M, Hirao A, Mukai M, Urai Y, Toda T, Tsuji S, Mitsui J.

Neurol Sci. 2026 Sep 11;47(10):775. doi: 10.1007/s10072-026-09361-1.

Pre-operative neural substrates of deep brain stimulation outcomes: A systematic review and cross-disorder network synthesis

Bai Y, Rodrigues TA, Yang AZ, Hu CK, Buongermini R, Hajiabadi MM, Son A, Keon K, Davidson B, Lipsman N, Hodaie M, Kalia SK, Fan H, Shi L, Yang A, Ibrahim GM, Gorodetsky C, Tang VM, Vetkas A, Fasano A, Zhang J, Lozano AM, Germann J, Boutet A.

Neurosci Biobehav Rev. 2026 Sep 17;191:106977. doi: 10.1016/j.neubiorev.2026.106977. Online ahead of print.

Analysis of multidimensional molecular mechanisms in Parkinson's disease and precise therapeutic strategies

Chen X, Zhao Z, Shen Y, Ji Y, Yao X, Gu X, Qi L, Sun H.

Exp Neurol. 2026 Sep 24;407:116041. doi: 10.1016/j.expneurol.2026.116041. Online ahead of print.

Synaptic vesicle glycoprotein 2A PET imaging in parkinsonian α-synucleinopathies: a systematic review

Garrou F, Leva L, Sacchetti GM, De Natale ER, Tondo G, Comi C.

J Neurol. 2026 Sep 7;273(10):570. doi: 10.1007/s00415-026-14123-2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias